The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 7, 2016, Pages 1461-1474

  Lyon, Debra E ^a   Cohen, Ronald ^a   Chen, Huaihou ^a   Kelly, Debra L ^a   Starkweather, Angela ^b   Ahn, Hyo Chol ^a   Jackson Cook, Colleen K ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Adjuvant; Breast cancer; Chemotherapy; Cognition; Memory

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ATTENTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; COGNITION; COGNITIVE FLEXIBILITY; COMPLEX ATTENTION; COMPOSITE MEMORY; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY CANCER; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEMORY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PSYCHOMOTOR SPEED; RESPONSE TIME; VERBAL MEMORY; VISUAL MEMORY; BREAST NEOPLASMS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; YOUNG ADULT;

EID: 84964328707     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-016-2163-y     Document Type: Article

References (52)

1. Aboalela N et al (2015) Perceived stress levels, chemotherapy, radiation treatment and tumor characteristics are associated with a persistent increased frequency of somatic chromosomal instability in women diagnosed with breast cancer: a one year longitudinal study. PLoS One 10(7):e0133380
2. Ahles TA (2012) Brain vulnerability to chemotherapy toxicities. Psycho-Oncology 21(11):1141–1148
3. Ahles TA, Root JC, Ryan EL (2012) Cancer-and cancer treatment–associated cognitive change: an update on the state of the science. J Clin Oncol 30(30):3675–3686
4. Andreotti C et al (2015) Reliable change in neuropsychological assessment of breast cancer survivors. Psycho Oncol. doi:10.1002/pon.3799
5. Alosco ML et al (2013) Reduced memory in fat mass and obesity-associated allele carriers among older adults with cardiovascular disease. Psychogeriatrics. doi:10.1111/j.1479-8301.2012.00424.x
6. Alosco ML et al (2014) Improved memory function two years after bariatric surgery. Obesity 22(1):32–38
7. Arpino G et al (2015) Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy. Breast Cancer Res Treat 154(1):127–132
8. Bakoyiannis I et al (2015) The impact of endocrine therapy on cognitive functions of breast cancer patients: a systematic review. Clin Drug Investig 36(2):109–118
9. Barker-Collo S et al (2015) Neuropsychological outcome and its correlates in the first year after adult mild traumatic brain injury: a population-based New Zealand study. Brain Inj 29(13–14):1604–1616
10. Bender CM et al (2015) Patterns of change in cognitive function with anastrozole therapy. Cancer 121(15):2627–2636
11. Bower JE et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743
12. Breckenridge LM et al (2012) Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psycho-Oncology 21(1):43–53
13. Buchanan ND et al (2015) Post-treatment neurocognition and psychosocial care among breast cancer survivors. Am J Prev Med 49(6):S498–S508
14. Calvio L et al (2010) Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med 52(2):219–227
15. Cheung YT et al (2015) Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol 26(7):1446–1451
16. Cohen S, Williamson G (1988) Perceived stress in a probability sample of the United States. Soc Psychol Health 13:123–128
17. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396
18. Crawford RD, Jonassaint CR (2015) Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case-control study. J Adv Nurs. doi:10.1111/jan.12755
19. Fan HGM et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23(31):8025–8032
20. Gualtieri CT, Johnson LG (2006) Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol 21(7):623–643
21. Gunstad J et al (2013) Obesity is associated with memory deficits in young and middle-aged adults. Eat Weight Disord Stud Anorex Bulim Obes 11(1):e15–e19
22. Henneghan A (2016) Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer 24(1):481–497
23. Hermelink K (2015) Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain. JNCI Monogr 2015(51):67–69
24. Hermelink K et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 109(9):1905–1913
25. Jansen C et al (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19(10):1647–1656
26. Jenkins V et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94(6):828–834
27. Kesler SR, Blayney DW (2015) Neurotoxic effects of anthracycline-vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol 2(2):185–192
28. Kool M et al (2015) Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients. Breast 24(3):224–229
29. Kyranou M et al (2013) Predictors of initial levels and trajectories of anxiety in women before and for 6 months after breast cancer surgery. Cancer Nurs 37(6):406–417
30. Lyon D et al (2015) Randomized sham controlled trial of cranial microcurrent stimulation for symptoms of depression, anxiety, pain, fatigue and sleep disturbances in women receiving chemotherapy for early-stage breast cancer. SpringerPlus 4(1):1–9
31. Mandelblatt JS et al (2014) Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?. J Clin Oncol. doi:10.1200/JCO.2013.54.2050
32. McDonald BC et al (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123(3):819–828
33. McDonald BC et al (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30(20):2500–2508
34. Mendoza TR et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186–1196
35. Meeske K et al (2007) Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL study report. Qual Life Res 16(6):947–960
36. Meskal I et al (2015) Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing. J Neurooncol 121(3):617–625
37. Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39:1
38. Ono M et al (2015) A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Front Oncol 5:59
39. Opdebeeck C et al (2015) Does cognitive reserve moderate the association between mood and cognition? A systematic review. Rev Clin Gerontol 25(03):181–193
40. Pérez S et al (2014) Posttraumatic stress symptoms in breast cancer patients: temporal evolution, predictors, and mediation. J Trauma Stress 27(2):224–231
41. Ramaiah R, Lam AM (2009) Postoperative cognitive dysfunction in the elderly. Anesthesiology clinics 27(3):485–496
42. Rele S et al (2015) An 8-week randomized, double-blind trial comparing efficacy, safety, and tolerability of 3 vilazodone dose-initiation strategies following switch from SSRIs and SNRIs in major depressive disorder. Prim Care Companion CNS Disord 17(4). doi:10.4088/PCC.4014m01734
43. Schagen SB et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85(3):640–650
44. Scherling C et al (2011) Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Front Hum Neurosci 5:122. doi: 10.3389/fnhum.2011.00122
45. Scherling C et al (2012) Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. J Clin Exp Neuropsychol 34(5):543–560
46. Schrepf A, Lutgendorf SK, Pyter LM (2015) Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. Brain Behav Immun 49:1–7
47. Snaith RP (2003) The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 1:29
48. Theadom A et al (2015) Frequency and impact of recurrent traumatic brain injury in a population-based sample. J Neurotrauma 32(10):674–681
49. van Dam FS et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90(3):210–218
50. Wefel JS et al (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12(7):703–708
51. Zwart W et al (2015) Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on? Nat Rev Clin Oncol 12(10):597–606
52. Zygouris S, Tsolaki M (2014) Computerized cognitive testing for older adults: A review. Am J Alzheimer’s Dis Other Demen 30(1):13–28